John Sullivan Interview on Merck, Health Care

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

July 30 (Bloomberg) -- John Sullivan, managing director at Leerink Swann LLC, talks about Merck & Co.'s second-quarter profit reported today. The second-largest U.S. drugmaker said earnings, excluding one-time items, were 86 cents a share, beating analyst estimates. Sullivan, speaking with Jon Erlichman on Bloomberg Television's "InsideTrack," also discusses the outlook for the health-care industry. (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change